Robert Wood Johnson Foundation Resources

How Does Alcohol and Drug Use Affect Care for Chronic Illnesses? The PRISM Program: Can primary care management of chronic illness be improved by identifying and addressing substance abuse? (2011)

http://www.rwjf.org/pr/product.jsp?id=72227

The Program of Research to Integrate Substance Use Issues into Mainstream Health Care, or PRISM, was designed in two phases to examine and address issues around moderate use of alcohol and other drugs that might compromise the care and management of common chronic illnesses (e.g., diabetes, hypertension, sleep disorders, asthma).

A Robert Wood Johnson Foundation Case Study: NIATx: A Case Study Tracing the History of Process Improvement in Addiction Prevention (2010)

http://www.rwjf.org/files/research/rwjf.casestudies.naitx.r7.pdf

Measuring performance and outcomes in addiction treatment has historically often been more informed by belief than by science with little regard towards data-driven standards of success. NIATx—which began as the Network for the Improvement of Addiction Treatment — was created through a partnership between the Robert Wood Johnson Foundation and the Center for Substance Abuse Treatment to use empirical data to improve quality among addiction treatment providers. This case study examines how NIATx translated research into evidence-based practice with a positive, measurable impact in the addiction prevention and treatment field.

The Evidence Doesn't Justify Steps By State Medicaid Programs To Restrict Opioid Addiction Treatment With Buprenorphine (2011)

http://www.rwjf.org/pr/product.jsp?id=72674

Many state Medicaid programs restrict access to buprenorphine, a prescription medication that relieves withdrawal symptoms for people addicted to heroin or other opiates. The reason is that officials fear that the drug is costlier or less safe than other therapies such as methadone. To find out if this is true, researchers compared spending, the use of services related to drug-use relapses, and mortality for 33,923 Massachusetts Medicaid beneficiaries receiving either buprenorphine, methadone, drug-free treatment, or no treatment between 2003 to 2007.

The Tobacco Campaigns of RWJF (2011): 

http://www.rwjf.org/pr/product.jsp?id=72051  

Second in the retrospective series — The Tobacco Campaigns of the Robert Wood Johnson Foundation and its Collaborators, 1991–2010 — is a body of work that was the result of the Foundation's commitment to create tobacco-cessation programs.